A "Phantom Recall" Does Not Comport with FDA's Regulatory Practice--Or Does It?: The Need for More Stringent Mandatory Reporting in FDA Matters.
- Published in:
- Iowa Law Review, 2012, v. 97, n. 5, p. 1839
- By:
- Publication type:
- Article
Works matching DE "JOHNSON %26 Johnson Healthcare Products (Company)"
Results: 5
1
2
J&J fined US$1.1bn for illegal marketing.
- Published in:
- TCE: The Chemical Engineer, 2012, n. 851, p. 15
- Publication type:
- Article
3
Seven days: 13-19 April 2012.
- Published in:
- Nature, 2012, v. 484, n. 7394, p. 292, doi. 10.1038/484292a
- Publication type:
- Article
4
J&J courts biotech in clusters.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 9, p. 769, doi. 10.1038/nbt0913-769
- By:
- Publication type:
- Article
5
Third-quarter biotech job picture.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 11, p. 1149, doi. 10.1038/nbt.2417
- By:
- Publication type:
- Article